Literature DB >> 19843542

PHF8, a gene associated with cleft lip/palate and mental retardation, encodes for an Nepsilon-dimethyl lysine demethylase.

Christoph Loenarz1, Wei Ge, Mathew L Coleman, Nathan R Rose, Christopher D O Cooper, Robert J Klose, Peter J Ratcliffe, Christopher J Schofield.   

Abstract

Mutations of human PHF8 cluster within its JmjC encoding exons and are linked to mental retardation (MR) and a cleft lip/palate phenotype. Sequence comparisons, employing structural insights, suggest that PHF8 contains the double stranded beta-helix fold and ferrous iron binding residues that are present in 2-oxoglutarate-dependent oxygenases. We report that recombinant PHF8 is an Fe(II) and 2-oxoglutarate-dependent N(epsilon)-methyl lysine demethylase, which acts on histone substrates. PHF8 is selective in vitro for N(epsilon)-di- and mono-methylated lysine residues and does not accept trimethyl substrates. Clinically observed mutations to the PHF8 gene cluster in exons encoding for the double stranded beta-helix fold and will therefore disrupt catalytic activity. The PHF8 missense mutation c.836C>T is associated with mild MR, mild dysmorphic features, and either unilateral or bilateral cleft lip and cleft palate in two male siblings. This mutant encodes a F279S variant of PHF8 that modifies a conserved hydrophobic region; assays with both peptides and intact histones reveal this variant to be catalytically inactive. The dependence of PHF8 activity on oxygen availability is interesting because the occurrence of fetal cleft lip has been demonstrated to increase with maternal hypoxia in mouse studies. Cleft lip and other congenital anomalies are also linked indirectly to maternal hypoxia in humans, including from maternal smoking and maternal anti-hypertensive treatment. Our results will enable further studies aimed at defining the molecular links between developmental changes in histone methylation status, congenital disorders and MR.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19843542      PMCID: PMC4673897          DOI: 10.1093/hmg/ddp480

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  29 in total

1.  X-linked mental retardation associated with cleft lip/palate maps to Xp11.3-q21.3.

Authors:  L E Siderius; B C Hamel; H van Bokhoven; F de Jager; B van den Helm; H Kremer; J A Heineman-de Boer; H H Ropers; E C Mariman
Journal:  Am J Med Genet       Date:  1999-07-30

2.  Protein structure prediction on the Web: a case study using the Phyre server.

Authors:  Lawrence A Kelley; Michael J E Sternberg
Journal:  Nat Protoc       Date:  2009       Impact factor: 13.491

3.  Histone demethylation by a family of JmjC domain-containing proteins.

Authors:  Yu-ichi Tsukada; Jia Fang; Hediye Erdjument-Bromage; Maria E Warren; Christoph H Borchers; Paul Tempst; Yi Zhang
Journal:  Nature       Date:  2005-12-18       Impact factor: 49.962

4.  Transverse limb deficiency, facial clefting and hypoxic renal damage: an association with treatment of maternal hypertension?

Authors:  J A Hurst; R S Houlston; A Roberts; S J Gould; W G Tingey
Journal:  Clin Dysmorphol       Date:  1995-10       Impact factor: 0.816

5.  Autism-associated familial microdeletion of Xp11.22.

Authors:  Y Qiao; X Liu; C Harvard; M J Hildebrand; E Rajcan-Separovic; J J A Holden; M E S Lewis
Journal:  Clin Genet       Date:  2008-05-21       Impact factor: 4.438

6.  Purification and characterization of an alpha-ketoisocaproate oxygenase of rat liver.

Authors:  P J Sabourin; L L Bieber
Journal:  J Biol Chem       Date:  1982-07-10       Impact factor: 5.157

7.  Incorporation of oxygen into the succinate co-product of iron(II) and 2-oxoglutarate dependent oxygenases from bacteria, plants and humans.

Authors:  Richard W D Welford; Joanna M Kirkpatrick; Luke A McNeill; Munish Puri; Neil J Oldham; Christopher J Schofield
Journal:  FEBS Lett       Date:  2005-09-26       Impact factor: 4.124

8.  Posttranslational hydroxylation of ankyrin repeats in IkappaB proteins by the hypoxia-inducible factor (HIF) asparaginyl hydroxylase, factor inhibiting HIF (FIH).

Authors:  Matthew E Cockman; David E Lancaster; Ineke P Stolze; Kirsty S Hewitson; Michael A McDonough; Mathew L Coleman; Charlotte H Coles; Xiaohong Yu; Ronald T Hay; Steven C Ley; Christopher W Pugh; Neil J Oldham; Norma Masson; Christopher J Schofield; Peter J Ratcliffe
Journal:  Proc Natl Acad Sci U S A       Date:  2006-09-26       Impact factor: 11.205

9.  Proteomics-based identification of novel factor inhibiting hypoxia-inducible factor (FIH) substrates indicates widespread asparaginyl hydroxylation of ankyrin repeat domain-containing proteins.

Authors:  Matthew E Cockman; James D Webb; Holger B Kramer; Benedikt M Kessler; Peter J Ratcliffe
Journal:  Mol Cell Proteomics       Date:  2008-10-20       Impact factor: 5.911

10.  Asparaginyl hydroxylation of the Notch ankyrin repeat domain by factor inhibiting hypoxia-inducible factor.

Authors:  Mathew L Coleman; Michael A McDonough; Kirsty S Hewitson; Charlotte Coles; Jasmin Mecinovic; Mariola Edelmann; Kristina M Cook; Matthew E Cockman; David E Lancaster; Benedikt M Kessler; Neil J Oldham; Peter J Ratcliffe; Christopher J Schofield
Journal:  J Biol Chem       Date:  2007-06-15       Impact factor: 5.157

View more
  58 in total

Review 1.  Molecular mechanisms and potential functions of histone demethylases.

Authors:  Susanne Marije Kooistra; Kristian Helin
Journal:  Nat Rev Mol Cell Biol       Date:  2012-04-04       Impact factor: 94.444

2.  PHF8 targets histone methylation and RNA polymerase II to activate transcription.

Authors:  Klaus Fortschegger; Petra de Graaf; Nikolay S Outchkourov; Frederik M A van Schaik; H T Marc Timmers; Ramin Shiekhattar
Journal:  Mol Cell Biol       Date:  2010-04-26       Impact factor: 4.272

3.  MassSQUIRM: An assay for quantitative measurement of lysine demethylase activity.

Authors:  Lauren P Blair; Nathan L Avaritt; Rong Huang; Phillip A Cole; Sean D Taverna; Alan J Tackett
Journal:  Epigenetics       Date:  2011-04-01       Impact factor: 4.528

4.  An atypical 12q24.31 microdeletion implicates six genes including a histone demethylase KDM2B and a histone methyltransferase SETD1B in syndromic intellectual disability.

Authors:  Jonathan D J Labonne; Kang-Han Lee; Shigeki Iwase; Il-Keun Kong; Michael P Diamond; Lawrence C Layman; Cheol-Hee Kim; Hyung-Goo Kim
Journal:  Hum Genet       Date:  2016-04-22       Impact factor: 4.132

5.  Development of homogeneous luminescence assays for histone demethylase catalysis and binding.

Authors:  Akane Kawamura; Anthony Tumber; Nathan R Rose; Oliver N F King; Michelle Daniel; Udo Oppermann; Tom D Heightman; Christopher Schofield
Journal:  Anal Biochem       Date:  2010-05-21       Impact factor: 3.365

6.  METTL23, a transcriptional partner of GABPA, is essential for human cognition.

Authors:  Rachel E Reiff; Bassam R Ali; Byron Baron; Timothy W Yu; Salma Ben-Salem; Michael E Coulter; Christian R Schubert; R Sean Hill; Nadia A Akawi; Banan Al-Younes; Namik Kaya; Gilad D Evrony; Muna Al-Saffar; Jillian M Felie; Jennifer N Partlow; Christine M Sunu; Pierre Schembri-Wismayer; Fowzan S Alkuraya; Brian F Meyer; Christopher A Walsh; Lihadh Al-Gazali; Ganeshwaran H Mochida
Journal:  Hum Mol Genet       Date:  2014-02-05       Impact factor: 6.150

Review 7.  Environmental mechanisms of orofacial clefts.

Authors:  Michael A Garland; Kurt Reynolds; Chengji J Zhou
Journal:  Birth Defects Res       Date:  2020-10-30       Impact factor: 2.344

Review 8.  Coordinated chromatin control: structural and functional linkage of DNA and histone methylation.

Authors:  Xiaodong Cheng; Robert M Blumenthal
Journal:  Biochemistry       Date:  2010-04-13       Impact factor: 3.162

Review 9.  Breathing-in epigenetic change with vitamin C.

Authors:  Asun Monfort; Anton Wutz
Journal:  EMBO Rep       Date:  2013-03-15       Impact factor: 8.807

Review 10.  Dysregulation of RNA polymerase I transcription during disease.

Authors:  K M Hannan; E Sanij; L I Rothblum; R D Hannan; R B Pearson
Journal:  Biochim Biophys Acta       Date:  2012-11-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.